Markets › India › NSE › GUFICBIO

Gufic Biosciences Ltd

NSE:GUFICBIOHealthcare

₹404.45−0.01%At closeAt close · Mon 19 Oct · ≈ AED 15.63 · Market cap $425.33M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	47.4%	45.7%	50.9%	50.5%	36.2%	36.0%	—	—
Operating margin	14.0%	16.6%	36.5%	35.9%	13.9%	12.8%	12.8%	+0.0 pts
Net margin	9.1%	12.3%	11.5%	10.7%	8.5%	6.8%	6.8%	+0.0 pts
EBITDA margin	17.6%	19.1%	19.9%	18.4%	16.9%	16.3%	—	—
Return on equity	25.5%	35.6%	22.9%	16.2%	11.6%	9.7%	9.7%	−0.0 pts
Return on assets	11.3%	18.4%	9.3%	7.9%	6.0%	4.8%	4.8%	+0.0 pts
Return on capital employed	29.8%	38.5%	44.0%	40.2%	14.5%	14.6%	—	—
Debt / equity	0.4×	0.2×	1.0×	0.6×	0.6×	0.6×	0.6×	−0.0%
Debt / assets	15.7%	12.3%	38.8%	30.5%	28.8%	30.2%	—	—
Interest coverage	5.0×	37.0×	30.7×	18.8×	4.9×	3.3×	—	—
Current ratio	1.6×	1.7×	1.6×	1.6×	1.6×	1.5×	1.5×	+0.0%
Quick ratio	1.0×	1.1×	1.0×	1.1×	1.1×	0.9×	—	—
Cash ratio	0.0×	0.1×	0.1×	0.0×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	1.2×	1.5×	0.8×	0.7×	0.7×	0.7×	—	—
Inventory turnover	2.7×	3.7×	1.9×	2.0×	2.4×	1.9×	—	—
Receivables turnover	3.9×	5.1×	3.4×	2.4×	2.6×	3.2×	—	—
Dividend payout	0.8%	1.0%	1.3%	1.1%	1.4%	1.6%	—	—